24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Molecular and biochemical basis <strong>of</strong> disease<br />

mature aging, skin laxity and generalised osteoporosis with spontaneous<br />

fractures . Crani<strong>of</strong>acial dysmorphism include a prominent forehead,<br />

ptosis, large protruding ears, droopy cheeks, flat malar region<br />

and prognathism .<br />

We ascertained a Libanese family in which 3 individuals presented<br />

with GO . The proband aged 1 ½ years is born from sixth-degree consanguineous<br />

parents, while in his 2 maternal uncles (born from a maternal<br />

uncle who married his second-degree cousin) the diagnosis was<br />

posed at 21 and 18 years, respectively . A genome-wide search was<br />

performed by genotyping the 3 affected individuals for microsatellite<br />

markers spaced around 10-15 cM from the ABI PRISM® Linkage Mapping<br />

Set seeking for adjacent homozygous markers . Among 6 positive<br />

regions, haplotype reconstruction and genotyping <strong>of</strong> other family members<br />

allowed the identification <strong>of</strong> a unique informative 47 centimorgan<br />

region <strong>of</strong> homozygosity, shared only by the 3 patients . We generated 9<br />

novel microsatellite markers in order to refine this region and outlined a<br />

locus for GO spanning from 155 .15 to 174 .71 megabases on the long<br />

arm <strong>of</strong> chromosome 1 (max Lod score 3 .2) . Sequencing <strong>of</strong> candidate<br />

genes within the linked interval is still in progress .<br />

P06.118<br />

Large deletions in 9q22.21-9q22.33 region <strong>of</strong> Gorlin syndrome<br />

patients<br />

V. Musani 1 , P. Gorry 2 , A. Basta-Juzbašić 3 , S. Levanat 1 ;<br />

1 Rudjer Boskovic Institute, Zagreb, Croatia, 2 Laboratoire de Génétique, Développement<br />

& Cancer, Université V. Ségalen, Bordeaux, France, 3 Department<br />

<strong>of</strong> Dermatovenerology, University School <strong>of</strong> Medicine, University <strong>of</strong> Zagreb,<br />

Zagreb, Croatia.<br />

Gorlin syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome<br />

(NBCCS) or Basal Cell Nevus Syndrome (BCNS), is an autosomal<br />

dominant disorder that is characterized by various developmental<br />

abnormalities, like cysts <strong>of</strong> the skin, jaw cysts, bone malformations and<br />

different tumors like basal cell carcinomas (BCC) as most frequent,<br />

and also medulloblastomas, meningiomas, fibromas <strong>of</strong> the ovaries and<br />

heart . The prevalence is estimated at one per 57000 . Phenotypical<br />

and genotypical diversity in Gorlin syndrome is referring to inactivating<br />

mutations in only one gene, PTCH, the human homologue <strong>of</strong> the Drosophila<br />

segment-polarity gene patched . PTCH is a tumor suppressor<br />

gene, located at 9q22 .3, encoding a 12-pass transmembrane glycoprotein<br />

that acts as an antagonist in the Hedgehog signaling pathway .<br />

The 34 kb gene contains 23 exons and there are several hundred<br />

mutations, spanning the whole gene . Although there are some recurring<br />

mutations, there are no apparent hot spots . Nonsense, frameshift,<br />

in-frame deletions, splicesite, and missense mutations all have been<br />

described in the Gorlin syndrome patients . In some cases large deletions<br />

in PTCH region have been reported . We developed semi-quantitative<br />

fluorescent multiplex PCR with polymorphic markers surrounding<br />

PTCH and analyzed the whole 9q22 region in 50 Gorlin syndrome<br />

cases from France and Croatia . In three cases we found large deletions<br />

from 4-7 megabases in length, giving some depth and additional<br />

indications for phenotype diversity <strong>of</strong> the Gorlin syndrome .<br />

P06.119<br />

Analysis <strong>of</strong> CTLA Gene Polymorphisms in spanish<br />

Graves`Patients<br />

M. Piñeiro-Gallego 1 , P. Álvarez-Vázquez 2 , L. Constela 3 , R. García -Mayor 2 , D.<br />

Valverde 1 ;<br />

1 Departamento de Bioquímica, Genética e Inmunología., Vigo, Spain, 2 Complejo<br />

Hospitalario Universitario de Vigo., Vigo, Spain, 3 Complejo Hospitalario<br />

Universitario de Vigo, Vigo, Spain.<br />

Graves’ disease (GD) is a common organ-specific autoimmune disease<br />

that affects 0 .5%-1% <strong>of</strong> Western population . It is a multifactorial<br />

disease that develops as the result <strong>of</strong> a complex interaction between<br />

genetic susceptibility genes and environmental factors . GD is characterized<br />

by diffuse goiter, ophthalmopathy, and anti-thyroid-stimulating<br />

hormone receptor antibodies .<br />

Numerous studies have demonstrated the linkage to several polymorphism<br />

<strong>of</strong> the CTLA4 gene . The CTLA4 gene is placed on chromosome<br />

2q33 and codifies the T cell receptor, which negatively modulates the<br />

immune response disabling the T cells . The aim <strong>of</strong> the present work<br />

was to determinate the contribution <strong>of</strong> C/T dimorphism in the promoter<br />

at position -318, the A/G dimorphism at position + 49 in exon 1, and<br />

the C/T60 dimorphism in the 3’UTR <strong>of</strong> the CTLA4 gene to the severity<br />

and manifestations <strong>of</strong> GD .<br />

A cohort <strong>of</strong> 98 patients, and 50 healthy controls were used to genotype<br />

these three SNPs by PCR-RFLPs .<br />

Results from +49A/G showed significant differences for the genotypes<br />

between Graves’ patients and controls . The frequency <strong>of</strong> GG is higher<br />

than in controls, a 6% <strong>of</strong> the controls were homozygous for the G allele,<br />

while for the patients group we found 22%. Furthermore, significant<br />

increase in the frequency <strong>of</strong> the G allele was found in Graves’<br />

patients compared with controls (X²= 6 .04, P=0 .0140)<br />

No statistically significant association has been found with the -318<br />

A/G and CT60 3’UTR polymorphism (X² = 17 .8, P =0 .1815; X² = 0 .79,<br />

P=0 .3729 respectively) .<br />

P06.120<br />

5 base pair deletions in Rab27a gene as hot spot in exon 6 in<br />

Griscelli syndrome (type ii)<br />

S. Shahkarami 1 , Z. Pourpak 2 , M. Houshmand 3 , A. Hamidieh 2 , M. Moin 2 ;<br />

1 Immunology, Asthma and Allergy Institue (IAARI), Tehran, Islamic Republic<br />

<strong>of</strong> Iran, 2 Immunology, Asthma and Allergy Institue (IAARI),, Tehran, Islamic<br />

Republic <strong>of</strong> Iran, 3 National Institute <strong>of</strong> Genetic Engineering and Biotechnology,<br />

and Medical Genetic Lab, Special Medical Center, Tehran, Iran, Tehran, Islamic<br />

Republic <strong>of</strong> Iran.<br />

Griscelli syndrome (GS), an autosomal recessive disorder, is characterized<br />

by a silver-gray sheen <strong>of</strong> the hair and the presence <strong>of</strong> large<br />

clusters <strong>of</strong> pigment in the hair shaft . GS can be associated to neurological<br />

impairment (GS1), immunodeficiency (GS2), or be isolated<br />

(GS3) .<br />

GS2 is caused by a mutation in the small GTPase RAB A gene . The<br />

aim <strong>of</strong> this study was to investigate mutations in RAB A gene, in a<br />

3 year-old boy who was referred to our center with immunodeficiency<br />

and silver gray sheen <strong>of</strong> the hair .<br />

Material and method: Genomic DNA was extracted from peripheral<br />

blood cells by salting out method. Five coding exons were amplified by<br />

PCR-Sequencing methods and sequenced to detect probable mutations<br />

in RAB A gene .<br />

Result: A homozygote deletion was found in exon 6 <strong>of</strong> the RAB A<br />

gene .<br />

Discussion: This deletion leads to a frame shift mutation in exon 6 and<br />

a premature stop codon. Clinical manifestations and immunodeficiency<br />

help physician to suspect diagnosis <strong>of</strong> GS II . As molecular analysis<br />

has provided an exact way to investigate mutations in immunodeficient<br />

patients like GS, it can be considered as a very useful method for<br />

definite diagnosis.<br />

Because <strong>of</strong> an amino acid deletion and frame shift in this exon, we<br />

conclude that this new deletion is pathogen . Other deletions were<br />

found and reported in the same exon as causative mutation . We believe<br />

that this region may be a hot spot for GS II and suggest that the<br />

first analysis for other patients must be done in this region.<br />

P06.121<br />

Association study <strong>of</strong> the glycogen synthase kinase-3 beta<br />

(GSK3beta) gene with Mood Disorders<br />

M. Gratacòs 1 , V. Soria 2 , E. Saus 1 , F. Vivarelli 1 , J. R. González 3 , J. Valero 4 , È.<br />

Martínez-Amorós 2 , M. Bayés 1 , A. Gutiérrez-Zotes 4 , J. M. Crespo 2,5 , L. Martorell 4 ,<br />

E. Vilella 4 , A. Labad 4 , J. M. Menchón 2,5 , J. Vallejo 2,5 , X. Estivill 1,6 , M. Urretavizcaya<br />

2,5 ;<br />

1 CIBERESP (CIBER en Epidemiología y Salud Pública), Genes and Disease<br />

Program and CeGen <strong>Barcelona</strong> Genotyping Node, Center for Genomic Regulation,<br />

<strong>Barcelona</strong>, Catalonia, Spain, 2 Mood Disorders Clinical and Research Unit,<br />

CIBER-SAM, Psychiatry Department, Bellvitge University Hospital, L’Hospitalet<br />

de Llobregat, <strong>Barcelona</strong>, Catalonia, Spain, 3 CREAL, Center for Research in<br />

Environmental Epidemiology, <strong>Barcelona</strong>, Catalonia, Spain, 4 Grup d’Investigació<br />

en Psiquiatria. Hospital Universitari Institut Pere Mata, Rovira i Virgili University,<br />

Reus, Tarragona, Catalonia, Spain, 5 Department <strong>of</strong> Clinical Sciences, Bellvitge<br />

Campus, <strong>Barcelona</strong> University, <strong>Barcelona</strong>, Catalonia, Spain, 6 Experimental and<br />

Health Sciences Department, Pompeu Fabra University, <strong>Barcelona</strong>, Catalonia,<br />

Spain.<br />

Glycogen synthase kinase-3beta (GSK3beta) is a key component <strong>of</strong><br />

the Wnt signaling pathway and is known to regulate such critical cellular<br />

functions as structure, gene expression, mobility and apoptosis .<br />

Recent findings support that GSK3beta may play a role in the pathophysiology<br />

and treatment <strong>of</strong> Mood Disorders (MD) . We hypothesize<br />

that genetic variants, including SNPs and CNVs (Copy Number Varia-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!